ERYTECH announces clinical trial authorizations in Finland and Spain for its European Phase IIb study in AML

ERYTECH announces it received authorizations for its Phase IIb GRASPA-ML clinical trial in Acute Myeloid Leukemia (AML) in Finland and Spain.